NPF Primer: GLP-1s Worth Considering as Adjunct for Select Psoriasis Patients

(MedPage Today) — GLP-1 receptor agonists represent a “biologically plausible and clinically intriguing adjunct” to the treatment of psoriasis for selected patients, concluded the authors of a National Psoriasis Foundation (NPF) “introduction.” The evidence showed…